Qualitative Research Among Physicians and Junior Doctors Into the Preconditions for Implementing a CDSS Based on AI in the ICU (KATRINA)

March 20, 2023 updated by: University Ghent

Qualitative Research Among Physicians and Junior Doctors Into the Preconditions for Implementing a Clinical Decision Support System (CDSS) Based on Artificial Intelligence (AI) in the ICU

The goal of this study is to explore the different attitudes and preconditions of potential end-users (doctors & physicians in training) required to achieve successful clinical implementation of models based on artificial intelligence (i.e. both machine learning and knowledge-driven techniques) as clinical decision support software.

Study Overview

Study Type

Observational

Enrollment (Actual)

69

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aalst, Belgium
        • OLV Aalst
      • Antwerpen, Belgium
        • ZNA Ziekenhuizen
      • Ghent, Belgium
        • Ghent University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Medical specialists or specialists in training working in intensive care at the time of the study.

Description

Inclusion Criteria:

  • Medical specialist or specialist in training working in intensive care at the time of the study.

Exclusion Criteria:

  • Age < 18 yo

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Baseline attitudes towards artificial intelligence and big data in medicine
Time Frame: baseline
Baseline attitudes towards artificial intelligence and big data in medicine will be collected through an online survey where participants will score their agreement with certain statements on a 6-point likert scale (Possible choices: Strongly agree - Agree - Neutral - Disagree - Totally Disagree - Not applicable).
baseline
Identify prerequisites that need to be fulfilled when AI/Big data based clinical decision support systems are used bedside from the viewpoint of the participants.
Time Frame: through study completion, an average of 1 year
Identify prerequisites that need to be fulfilled when AI/Big data based clinical decision support systems are used bedside and identify the most important ones for different aspects of the antimicrobial stewardship cycle from the viewpoint of the participants through a group discussion. Reporting: frequencies.
through study completion, an average of 1 year
Identify subdomains of the antimicrobial stewardship cycle with potential for AI/Big data application
Time Frame: through study completion, an average of 1 year
Identify subdomains of the antimicrobial stewardship cycle for which participants think AI/Big data might be of use through a group discussion/interview. Reporting: frequencies.
through study completion, an average of 1 year
Identify perceived potential benefits and harms when applying AI in the antimicrobial stewardship cycle.
Time Frame: through study completion, an average of 1 year
Identify perceived potential benefits and harms when applying AI in the antimicrobial stewardship cycle through a group discussion. Reporting: frequencies.
through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subgroup analysis: age
Time Frame: through study completion, an average of 1 year
Explore if there are variations in the above mentioned outcomes when taking into account the age (years) of the participants.
through study completion, an average of 1 year
Subgroup analysis: gender
Time Frame: through study completion, an average of 1 year
Explore if there are variations in the above mentioned outcomes when taking into account the gender of the participants.
through study completion, an average of 1 year
Subgroup analysis: working environment (type of hospital, type of ICU)
Time Frame: through study completion, an average of 1 year
Explore if there are variations in the above mentioned outcomes when taking into account the working environment (University hospital vs non University hospital, small size hospital vs large size hospital, type of ICU (medical, surgery, mixed ICU, intermediate care)) - data which is collected in the baseline questionnaire) of the participants.
through study completion, an average of 1 year
Subgroup analysis: working experience (basic training and clinical experience).
Time Frame: through study completion, an average of 1 year
Explore if there are variations in the above mentioned outcomes when taking into account the working experience (type of basic training (anesthesiology, internal medicine, surgery, other), clinical experience (years) - data which is collected in the baseline questionnaire) of the participants.
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jan De Waele, MD, PhD, University Ghent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 13, 2022

Primary Completion (Actual)

October 31, 2022

Study Completion (Actual)

October 31, 2022

Study Registration Dates

First Submitted

February 22, 2022

First Submitted That Met QC Criteria

March 21, 2022

First Posted (Actual)

March 31, 2022

Study Record Updates

Last Update Posted (Actual)

March 22, 2023

Last Update Submitted That Met QC Criteria

March 20, 2023

Last Verified

October 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • BC-9892

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

If possible and feasible, anonymised survey data as well as transcript data from the group discussions will be made available on request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Artificial Intelligence

Clinical Trials on Survey

Subscribe